Latest Health News

Page 136 of 171
Nanoveu Limited has completed its strategic acquisition of EMASS, advancing its foothold in ultra-low-power AI-driven edge computing. The company also strengthened its leadership team and secured additional capital to fuel growth.
Sophie Babbage
Sophie Babbage
30 Apr 2025
AdNeo Limited reports a positive operating cash flow for Q3 FY25, driven by a 60% surge in customer receipts and cost savings exceeding targets. Strategic SaaS contracts and platform upgrades underpin its growth trajectory.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Cardiex reports strong early sales momentum for its CONNEQT Pulse device with approximately 3,000 units sold or contracted since its mid-January launch, supported by innovative app features and operational efficiencies. Despite regulatory delays in the US pharma sector and tariff challenges, the company is positioned for scalable growth and category leadership in preventative cardiovascular care.
Ada Torres
Ada Torres
30 Apr 2025
Anatara Lifesciences reports mixed results from its Phase II GaRP-IBS trial, missing the primary efficacy target but showing significant improvements in anxiety and patient-reported relief, while advancing its anti-obesity pre-clinical program.
Ada Torres
Ada Torres
30 Apr 2025
Terragen Holdings has launched its new probiotic products for ruminants, initiated multiple key trials including methane mitigation and crop yield studies, and secured a US patent allowance, positioning itself for global market expansion.
Ada Torres
Ada Torres
30 Apr 2025
UNITH Ltd reports a 9.3% rise in Q3 FY25 cash receipts driven by its B2C subscription surge and a landmark pharmaceutical contract, alongside strategic platform upgrades and leadership changes.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Enlitic reported a 5.8% revenue increase in Q1 CY25, strengthened its collaboration with GE HealthCare, and accelerated integration of Laitek, positioning itself for operational cashflow break-even by the end of 2025.
Victor Sage
Victor Sage
30 Apr 2025
Santos Limited’s 2024 Annual Report reveals a 5% decline in production and a 9% drop in sales revenue, yet the company progresses its climate transition with key CCS projects and emissions reductions.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Oakridge International Limited reported strong operational and financial progress for Q1 2025, highlighting increased trading income, positive cash flow, and a robust sales pipeline in healthcare IoT technology despite ongoing legal discussions.
Victor Sage
Victor Sage
30 Apr 2025
EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.
Ada Torres
Ada Torres
30 Apr 2025
DGR Global Limited reported steady progress in project generation and strategic investments during Q1 2025, while navigating ongoing legal challenges and securing a $23.5 million funding facility to support operations and refinancing.
Maxwell Dee
Maxwell Dee
30 Apr 2025
RooLife Group reported a strategic quarter marked by the launch of its TikTok UK marketplace, expansion of its own health product range, and a significant capital raise backed by a key Chinese partner.
Victor Sage
Victor Sage
30 Apr 2025